National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

News & Events
 News Releases
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  1999
  1998
  1997
  1996
  1995
  By Topic
 Qs & As
 Media Inquiries
 Events & Calendars
 NIAID Discovery News
 Focus on Features
 NIAID in the News
 Resources


NIH Logo National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov
FOR IMMEDIATE RELEASE
Tuesday, October 26, 2004
Media Contact:
Jennifer Wenger
(301) 402-1663
niaidnews@niaid.nih.gov

News Advisory

NIAID Media Roundtable: On the Frontlines of Flu Research

WHAT

As concerns about the flu dominate the headlines, please join us as Anthony S. Fauci, M.D., NIAID director, briefs the media about frontline laboratory and clinical research, including

  • future technologies for the development and manufacture of vaccines, including reverse genetics, cell-culture techniques and recombinant proteins
  • NIAID-supported clinical trials  to study herd immunity and the head-to-head efficacy of different vaccines
  • new diagnostic techniques for rapidly detecting avian flu strains in the event of a pandemic

The event will also serve to launch NIAID’s updated and expanded Focus on Flu Web site, spotlighting cutting-edge NIAID-supported research and graphics that illuminate concepts important to understanding influenza research such as reverse genetics and antigenic shift and drift.

Following the briefing, Dr. Fauci and other NIAID staff will take questions from the audience.

WHO

Anthony S. Fauci, M.D., NIAID director

Brian Murphy, M.D., co-chief, NIAID Laboratory of Infectious Diseases

Kanta Subbarao, M.D., senior investigator, Respiratory Viruses Section, NIAID Laboratory of Infectious Diseases

Linda Lambert, Ph.D., acting chief, NIAID Division of Microbiology and Infectious Diseases (DMID), Influenza, SARS, and Related Viral Respiratory Diseases Section

Cristina Cassetti, Ph.D., program officer, NIAID DMID Influenza, SARS, and Related Viral Respiratory Diseases Section

Maria Giovanni, Ph.D., chief, NIAID DMID Genomics and Technology Development Section

WHEN

Monday, Nov. 15, 10:30 – 11:30 a.m. Eastern Time

WHERE

NIH Campus, Natcher Conference Center, Room E1/E2 Bethesda, MD

Attendees are strongly encouraged to use the Metro. The NIH campus can be easily accessed via the Medical Center stop on the Metro’s Red Line. For information on transportation to and parking and security at NIH, go to http://www.nih.gov/about/visitorsecurity.htm.

REGISTER

Advanced registration is requested.  To register, contact Jennifer Wenger or Laurie K. Doepel at (301) 402-1663, or e-mail jwenger@niaid.nih.gov. Individuals with disabilities who need Sign Language Interpreters or reasonable accommodation to participate in this roundtable should contact Jennifer Wenger or Laurie K. Doepel. Such requests should be made at least 5 days in advance of the event.


NIAID is a component of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.

back to top



See Also

Media Contact Info

News Releases by Topic


NIH Logo

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

NIAID Logo

Search in News & Events
 
Print Icon Print this page
E-mail Icon E-mail this page

See Also

Media Contact Info

News Releases by Topic